Whelan, Kristine C – Trademark Portfolio

Entity Type: 01

Whelan, Kristine C has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include BLUE BUDDHA. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 36 (Insurance & Financial) and Class 5 (Pharmaceuticals). This trademark owner is based in westerly, RI.

9 Avondale Road

westerly, RI 02891

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Whelan, Kristine C's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Whelan, Kristine C have?

Whelan, Kristine C has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Whelan, Kristine C file in?

Whelan, Kristine C files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Whelan, Kristine C's most well-known trademarks?

Whelan, Kristine C's registered trademark portfolio includes well-known marks such as BLUE BUDDHA. These are among 1 currently registered trademark in the portfolio.

What is Whelan, Kristine C's trademark registration success rate?

Whelan, Kristine C has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.